Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Veng-Pedersen

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1985
The determination of mean residence time using statistical moments: it is correctW R Gillespie, P Veng-Pedersen
Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric seriesR A Herman, P Veng-Pedersen
Journal of Pharmaceutical Sciences|August 1, 1991
Exact dosing times calculations in linear pharmacokineticsP Veng-Pedersen, J G Wagner
Biopharmaceutics & Drug Disposition|November 1, 1988
A note regarding curve fitting with a sum of exponentialsR A Herman, P Veng-Pedersen
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1985
A polyexponential deconvolution method. Evaluation of the "gastrointestinal bioavailability" and mean in vivo dissolution time of some ibuprofen dosage formsW R Gillespie, P Veng-Pedersen
Journal of Pharmaceutical Sciences|September 1, 1993
Application of neural networks to pharmacodynamicsP Veng-Pedersen, N B Modi
Pharmaceutical Research|January 1, 1994
Validation of a variable direction hysteresis minimization pharmacodynamic approach: cardiovascular effects of alfentanilN B Modi, P Veng-Pedersen
Journal of Pharmaceutical Sciences|October 1, 1989
Center of gravity of drug level curves: a model-independent parameter useful in bioavailability studiesP Veng-Pedersen, L G Tillman
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1992
Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?P Veng-Pedersen, N B Modi
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1991
Optimal extravascular dosing intervalsP Veng-Pedersen, N B Modi
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1985
The determination of mean residence time using statistical moments: it is correctW R Gillespie, P Veng-Pedersen
Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric seriesR A Herman, P Veng-Pedersen
Journal of Pharmaceutical Sciences|August 1, 1991
Exact dosing times calculations in linear pharmacokineticsP Veng-Pedersen, J G Wagner
Biopharmaceutics & Drug Disposition|November 1, 1988
A note regarding curve fitting with a sum of exponentialsR A Herman, P Veng-Pedersen
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1985
A polyexponential deconvolution method. Evaluation of the "gastrointestinal bioavailability" and mean in vivo dissolution time of some ibuprofen dosage formsW R Gillespie, P Veng-Pedersen
Journal of Pharmaceutical Sciences|September 1, 1993
Application of neural networks to pharmacodynamicsP Veng-Pedersen, N B Modi
Pharmaceutical Research|January 1, 1994
Validation of a variable direction hysteresis minimization pharmacodynamic approach: cardiovascular effects of alfentanilN B Modi, P Veng-Pedersen
Journal of Pharmaceutical Sciences|October 1, 1989
Center of gravity of drug level curves: a model-independent parameter useful in bioavailability studiesP Veng-Pedersen, L G Tillman
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1992
Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?P Veng-Pedersen, N B Modi
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1991
Optimal extravascular dosing intervalsP Veng-Pedersen, N B Modi
Pageof 11